Your DNA is a book written in just four letters — A, T, G and C — about 3 billion letters long. Every human shares roughly 99.9% of that book. The 0.1% that differs, some 4 to 5 million positions, is what makes you biologically you. Whole genome sequencing (WGS) is the only consumer method that reads the entire book, letter by letter.
How it actually works
A sequencing machine reads your DNA in millions of short fragments and reassembles them against the human reference genome. To be confident about each letter, it reads every position multiple times — this is called coverage. Consumer WGS is typically sold at 30x (each position read ~30 times); higher-quality services offer 40x, which improves accuracy for rare and hard-to-call variants.
What you get back
WGS produces three standard files:
- FASTQ — the raw sequencing reads.
- BAM — those reads aligned to the reference genome.
- VCF — the list of every position where your DNA differs from the reference. This is the file interpretation is built on.
WGS vs. a 23andMe-style chip
A genotyping chip (used by 23andMe and AncestryDNA) does not read your whole genome. It checks about 700,000 pre-selected positions — enough for ancestry and common wellness variants, but blind to everything else. WGS reads all 3 billion positions, which means it can detect rare personal variants a chip was never designed to see.
There is a second, subtler advantage: re-analysability. A chip is fixed at the positions chosen when it was manufactured. A WGS file is complete, so as science discovers new variants over the coming years, the same file can be re-interpreted — without a new sample.
What WGS is used for
Once you have a VCF, the value is in interpretation: cross-referencing your variants against clinical databases (such as ClinVar and gnomAD) and predictors to understand disease risk, how you metabolize medications and supplements (pharmacogenomics), nutrition-related variants (nutrigenomics), and traits from caffeine sensitivity to lactose tolerance.
This article is a plain-English introduction. GenomeXR is an independent, non-commercial resource and sells no tests; every explanation is grounded in the published scientific literature.